BACKGROUND:Oncologic emergencies associated with multiple myeloma include myelosuppression (anemia, neutropenia, and thrombocytopenia), bone-related emergencies, and acute renal failure. .OBJECTIVES:This article reviews the pathophysiology of these multiple myeloma-associated oncology emergencies and provides a framework for assessment and effective intervention. .METHODS:A comprehensive review of the levels of evidence, focusing on assessment, diagnosis, comorbidities, treatment, ongoing monitoring, and patient education, are presented to support the plan of care for at-risk patients. .FINDINGS:Attention to signs and symptoms is the foundation for preventing these emergencies or managing additional escalation of symptoms
Skeletal-related events (SREs) are common bone complications in multiple myeloma (MM). However, ther...
Purpose: using the example of our own clinical case to demonstrate the complexity of diagnostics at ...
The spectrum of kidney disease-associated monoclonal immunoglobulin and plasma cell malignancies is ...
BACKGROUND:Oncologic emergencies associated with multiple myeloma include myelosuppression (anemia, ...
Multiple myeloma is a malignant disorder of plasma cells, characterized by uncontrolled and progress...
BACKGROUND:About 85% of patients with multiple myeloma develop bone disease. In these patients, lyti...
International audienceSymptomatic multiple myeloma is commonly complicated by acute kidney injury th...
Multiple myeloma is an oncological disease of plasma cells which causes bone pain, anemia and kidney...
ABSTR ACT: Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM). More t...
Multiple myeloma is the second most common haematological malignancy in high-income countries, and t...
Multiple myeloma (MM) is a neoplastic clonal proliferation of plasma cells in the bone marrow microe...
haematological malignancy with reported mortality of 10–20 % within the first 2 months of presentati...
International audienceRenal failure remains a principal cause of morbidity for patients with multipl...
The diagnosis of multiple myeloma (MM) can be challenging, especially in patients with light-chain o...
Multiple myeloma, also known as plasma cell myeloma is the most important subgroup amongst the plasm...
Skeletal-related events (SREs) are common bone complications in multiple myeloma (MM). However, ther...
Purpose: using the example of our own clinical case to demonstrate the complexity of diagnostics at ...
The spectrum of kidney disease-associated monoclonal immunoglobulin and plasma cell malignancies is ...
BACKGROUND:Oncologic emergencies associated with multiple myeloma include myelosuppression (anemia, ...
Multiple myeloma is a malignant disorder of plasma cells, characterized by uncontrolled and progress...
BACKGROUND:About 85% of patients with multiple myeloma develop bone disease. In these patients, lyti...
International audienceSymptomatic multiple myeloma is commonly complicated by acute kidney injury th...
Multiple myeloma is an oncological disease of plasma cells which causes bone pain, anemia and kidney...
ABSTR ACT: Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM). More t...
Multiple myeloma is the second most common haematological malignancy in high-income countries, and t...
Multiple myeloma (MM) is a neoplastic clonal proliferation of plasma cells in the bone marrow microe...
haematological malignancy with reported mortality of 10–20 % within the first 2 months of presentati...
International audienceRenal failure remains a principal cause of morbidity for patients with multipl...
The diagnosis of multiple myeloma (MM) can be challenging, especially in patients with light-chain o...
Multiple myeloma, also known as plasma cell myeloma is the most important subgroup amongst the plasm...
Skeletal-related events (SREs) are common bone complications in multiple myeloma (MM). However, ther...
Purpose: using the example of our own clinical case to demonstrate the complexity of diagnostics at ...
The spectrum of kidney disease-associated monoclonal immunoglobulin and plasma cell malignancies is ...